| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |